| Compare
Ventricular Assist Devices
(VADs)
Functional
Generations 4 & 5
|
-
Over 440 implants worldwide of the MicroMed VAD account
for more than 130 patient years of life
- CE approved Pediatric VAD ·
CE approved Adult VAD
About MicroMed Cardiovascular, Inc.
In 1984, Dr. Michael DeBakey and
Dr. George Noon performed heart transplant surgery on
NASA-Johnson Space Center (JSC) engineer David Saucier,
following a severe heart attack. Six months later, Saucier
returned to JSC with the desire to apply spacecraft
technology to help people with diseased hearts. As early
as 1987, informal meetings began with NASA engineers
and Drs. DeBakey and Noon to discuss the design of a
low-cost, low-power, implantable ventricular assist
device (VAD). NASA began formal funding of the development
of the device four years later, bringing outer space
technology to inner space applications.
In 1996, MicroMed Cardiovascular,
Inc. received an exclusive license from NASA to use
this rotary blood pump for cardiovascular applications.
MicroMed then began the development of the critical
support systems that would allow the device (system)
to be approved by regulatory agencies and to be utilized
in lifesaving applications in humans. European clinical
trials of the DeBakey VAD® began
in November 1998 and CE Mark certification was awarded
in April 2001 for both the Adult and Pediatric VADs.
The DeBakey VAD® Child received FDA approval in February
2004. The U.S. clinical trial for the Adult VAD is currently
underway.
MicroMed's world headquarters
and its EN ISO 13485:2003/AC:2007 certified manufacturing facility
is located in Houston, Texas. MicroMed has an international
office located in Zurich, Switzerland.
For more information,
visit:
|
